Lymphoma, Small Lymphocytic
Showing 1 - 25 of >10,000
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +5 more
- Nemtabrutinib
- +2 more
- (no location specified)
Jul 21, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Nemtabrutinib
- +2 more
- (no location specified)
Nov 22, 2023
Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small
Recruiting
- Relapsed or Refractory CD19+ B-cell Lymphoma
- +2 more
- TBI-2001
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jul 26, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Houston, TexasM D Anderson Cancer Center
Nov 17, 2022
Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance
Not yet recruiting
- Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
- (no location specified)
Dec 16, 2022
Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Not yet recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Orelabrutinib in the Treatment of CLL/SLL
Not yet recruiting
- CLL/SLL
- (no location specified)
Jul 26, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- TQB3909 tablet
-
Zhengzhou, Henan, China
- +1 more
Jul 17, 2023
Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Active, not recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +3 more
-
Duarte, California
- +2 more
Oct 7, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Leukemia
-
Boston, Massachusetts
- +1 more
Nov 14, 2022
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)
Not yet recruiting
- Relapsed Non-Hodgkin Lymphoma
- +6 more
- (no location specified)
Apr 12, 2023
Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small
Recruiting
- CLL/SLL
-
Jinan, Shandong, ChinaDepartment of Hematology, Shandong Provincial Hospital Affiliate
Jun 16, 2023
Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +5 more
- Ibrutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Acalabrutinib
- +4 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2023
Tumors, Leukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic Trial in Victoria (Intermittent fast)
Active, not recruiting
- Neoplasms
- +5 more
- Intermittent fast
-
Victoria, British Columbia, CanadaEleah Stringer
Mar 15, 2022
Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)
Active, not recruiting
- Leukemia
- Lymphoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 30, 2023
Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- Acalabrutinib
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Leukemia
- Nemtabrutinib
- +7 more
- (no location specified)
Nov 30, 2022
Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)
Recruiting
- Chronic Lymphocytic Leukemia
- +3 more
-
Whittier, CaliforniaInnovative Clinical Research Institute
Aug 8, 2022
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Cyclophosphamide injection
- +2 more
-
Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
Jan 18, 2023
Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute
Active, not recruiting
- Small Lymphocytic Lymphoma
- CLL (Chronic Lymphocytic Leukemia)
- Fludarabine Phosphate
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022
Newly Diagnosed Asymptomatic High-Risk Chronic Lymphocytic
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- EQ-5D-5L Instrument
- +2 more
-
Vancouver, British Columbia, Canada
- +3 more
Dec 12, 2022